Kite Pharma, one of the companies chasing a new generation of cancer drugs called chimeric antigen receptor T - cell (CAR - T) therapies, announced a patient death in a clinical trial of its experimental KTE - C19. (fortune.com)
What makes the treatment so fascinating is its underlying technology, called chimeric antigen receptor T - cell (CAR - T). (fortune.com)
Research into such therapies as chimeric antigen receptor T cells (CAR - T) cancer therapies and stem - cell regenerative medicines demand the isolation and purification of viable and functional target cells. (bioprocessintl.com)